Correlation Between Inozyme Pharma and Instil Bio
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Instil Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Instil Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Instil Bio, you can compare the effects of market volatilities on Inozyme Pharma and Instil Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Instil Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Instil Bio.
Diversification Opportunities for Inozyme Pharma and Instil Bio
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inozyme and Instil is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Instil Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Instil Bio and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Instil Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Instil Bio has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Instil Bio go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Instil Bio
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Instil Bio. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 2.22 times less risky than Instil Bio. The stock trades about 0.0 of its potential returns per unit of risk. The Instil Bio is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 758.00 in Instil Bio on September 14, 2024 and sell it today you would earn a total of 1,439 from holding Instil Bio or generate 189.84% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Instil Bio
Performance |
| Timeline |
| Inozyme Pharma |
| Instil Bio |
Inozyme Pharma and Instil Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Instil Bio
The main advantage of trading using opposite Inozyme Pharma and Instil Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Instil Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Instil Bio will offset losses from the drop in Instil Bio's long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Instil Bio vs. Puma Biotechnology | Instil Bio vs. Iovance Biotherapeutics | Instil Bio vs. Day One Biopharmaceuticals | Instil Bio vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |